000			01935 a2200565 4500
005			20250514223637.0
264		0	_c20050510
008			200505s 0 0 eng d
022			_a0003-9942
024	7		_a10.1001/archneur.62.4.569 _2doi
040			_aNLM _beng _cNLM
100	1		_aSastre-Garriga, J
245	0	0	_aMetabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. _h[electronic resource]
260			_bArchives of neurology _cApr 2005
300			_a569-73 p. _bdigital
500			_aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAge of Onset
650	0	4	_aAged
650	0	4	_aAspartic Acid _xanalogs & derivatives
650	0	4	_aBiomarkers
650	0	4	_aCase-Control Studies
650	0	4	_aCerebral Cortex _xmetabolism
650	0	4	_aCholine _xanalysis
650	0	4	_aDisability Evaluation
650	0	4	_aDisease Progression
650	0	4	_aFemale
650	0	4	_aGlutamic Acid _xmetabolism
650	0	4	_aHumans
650	0	4	_aInositol _xanalysis
650	0	4	_aMagnetic Resonance Spectroscopy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Sclerosis, Chronic Progressive _xdiagnosis
650	0	4	_aNerve Fibers, Myelinated _xmetabolism
650	0	4	_aNeurons _xmetabolism
650	0	4	_aNeuropil _xmetabolism
650	0	4	_aPhosphocreatine _xanalysis
650	0	4	_aPredictive Value of Tests
650	0	4	_aReference Values
650	0	4	_aStatistics as Topic
700	1		_aIngle, G T
700	1		_aChard, D T
700	1		_aRamió-Torrentà, Lí
700	1		_aMcLean, M A
700	1		_aMiller, D H
700	1		_aThompson, A J
773	0		_tArchives of neurology _gvol. 62 _gno. 4 _gp. 569-73
856	4	0	_uhttps://doi.org/10.1001/archneur.62.4.569 _zAvailable from publisher's website
999			_c15493166 _d15493166